5 research outputs found
Human Anti-Lipopolysaccharid (LPS) antibodies against Legionella with high species specificity.
Legionella are Gram-negative bacteria that are ubiquitously present in natural and man-made water reservoirs. When humans inhale aerosolized water contaminated with Legionella, alveolar macrophages can be infected, which may lead to a life-threatening pneumonia called Legionnaires' disease. Due to the universal distribution of Legionella in water and their potential threat to human health, the Legionella concentration in water for human use must be strictly monitored, which is difficult since the standard detection still relies on lengthy cultivation and analysis of bacterial morphology. In this study, an antibody against L. pneumophila has been generated from the naΓ―ve human HAL antibody libraries by phage-display for the first time. The panning was performed on whole bacterial cells in order to select antibodies that bind specifically to the cell surface of untreated Legionella. The bacterial cell wall component lipopolysaccharide (LPS) was identified as the target structure. Specific binding to the important pathogenic L. pneumophila strains Corby, Philadelphia-1 and Knoxville was observed, while no binding was detected to seven members of the families Enterobacteriaceae, Pseudomonadaceae or Clostridiaceae. Production of this antibody in the recombinant scFv-Fc format using either a murine or a human Fc part allowed the set-up of a sandwich-ELISA for detection of Legionella cells. The scFv-Fc construct proved to be very stable, even when stored for several weeks at elevated temperatures. A sensitivity limit of 4,000 cells was achieved. The scFv-Fc antibody pair was integrated on a biosensor, demonstrating the specific and fast detection of L. pneumophila on a portable device. With this system, 10,000 Legionella cells were detected within 35 min. Combined with a water filtration/concentration system, this antibody may be developed into a promising reagent for rapid on-site Legionella monitoring
Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets
Psammaplin A (11c) is a marine metabolite previously reported to be a potent inhibitor of two classes of epigenetic enzymes: histone deacetylases and DNA methyltransferases. The design and synthesis of a focused library based on the psammaplin A core has been carried out to probe the molecular features of this molecule responsible for its activity. By direct in vitro assay of the free thiol generated upon reduction of the dimeric psammaplin scaffold, we have unambiguously demonstrated that 11c functions as a natural prodrug, with the reduced form being highly potent against HDAC1 in vitro (IC(50) 0.9 nM). Furthermore, we have shown it to have high isoform selectivity, being 360-fold selective for HDAC1 over HDAC6 and more than 1000-fold less potent against HDAC7 and HDAC8. SAR around our focused library revealed a number of features, most notably the oxime functionality to be important to this selectivity. Many of the compounds show significant cytotoxicity in A549, MCF7, and W138 cells, with the SAR of cytotoxicity correlating to HDAC inhibition. Furthermore, compound treatment causes upregulation of histone acetylation but little effect on tubulin acetylation. Finally, we have found no evidence for 11c functioning as a DNMT inhibitor
Defining the Mechanism of Action and Enzymatic Selectivity of Psammaplin A against Its Epigenetic Targets
Psammaplin A (<b>11c</b>) is a marine metabolite
previously
reported to be a potent inhibitor of two classes of epigenetic enzymes:
histone deacetylases and DNA methyltransferases. The design and synthesis
of a focused library based on the psammaplin A core has been carried
out to probe the molecular features of this molecule responsible for
its activity. By direct in vitro assay of the free thiol generated
upon reduction of the dimeric psammaplin scaffold, we have unambiguously
demonstrated that <b>11c</b> functions as a natural prodrug,
with the reduced form being highly potent against HDAC1 in vitro (IC<sub>50</sub> 0.9 nM). Furthermore, we have shown it to have high isoform
selectivity, being 360-fold selective for HDAC1 over HDAC6 and more
than 1000-fold less potent against HDAC7 and HDAC8. SAR around our
focused library revealed a number of features, most notably the oxime
functionality to be important to this selectivity. Many of the compounds
show significant cytotoxicity in A549, MCF7, and W138 cells, with
the SAR of cytotoxicity correlating to HDAC inhibition. Furthermore,
compound treatment causes upregulation of histone acetylation but
little effect on tubulin acetylation. Finally, we have found no evidence
for <b>11c</b> functioning as a DNMT inhibitor